CRIS Current Research Information System

GALLINELLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.047
AS - Asia 6.526
EU - Europa 5.563
AF - Africa 428
SA - Sud America 391
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 19.966
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.969
CN - Cina 2.056
SG - Singapore 1.741
VN - Vietnam 1.406
GB - Regno Unito 1.336
IT - Italia 1.309
DE - Germania 656
SE - Svezia 492
HK - Hong Kong 486
UA - Ucraina 365
IN - India 349
RU - Federazione Russa 321
BR - Brasile 272
FR - Francia 248
IE - Irlanda 201
KR - Corea 160
CH - Svizzera 134
ZA - Sudafrica 115
EE - Estonia 109
JP - Giappone 109
NL - Olanda 102
CI - Costa d'Avorio 86
TG - Togo 85
AR - Argentina 75
BG - Bulgaria 73
SC - Seychelles 59
CA - Canada 44
FI - Finlandia 44
IR - Iran 39
JO - Giordania 39
NG - Nigeria 39
AT - Austria 37
IQ - Iraq 36
BE - Belgio 33
ID - Indonesia 30
PL - Polonia 25
MX - Messico 24
ES - Italia 18
KE - Kenya 13
PK - Pakistan 12
RO - Romania 11
CO - Colombia 10
CZ - Repubblica Ceca 9
EC - Ecuador 9
GR - Grecia 9
TR - Turchia 9
CM - Camerun 8
LT - Lituania 8
PE - Perù 8
UZ - Uzbekistan 8
DO - Repubblica Dominicana 7
TH - Thailandia 7
AU - Australia 6
CL - Cile 6
HR - Croazia 6
LB - Libano 6
BD - Bangladesh 5
EG - Egitto 5
PY - Paraguay 5
HU - Ungheria 4
PH - Filippine 4
SA - Arabia Saudita 4
TW - Taiwan 4
CY - Cipro 3
IL - Israele 3
MA - Marocco 3
RS - Serbia 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DZ - Algeria 2
EU - Europa 2
KH - Cambogia 2
LV - Lettonia 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TD - Ciad 2
TN - Tunisia 2
TZ - Tanzania 2
UG - Uganda 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BO - Bolivia 1
CR - Costa Rica 1
CV - Capo Verde 1
DJ - Gibuti 1
GE - Georgia 1
GY - Guiana 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
Totale 19.965
Salva come PNG Salva come JPEG
Città #
Southend 1.166
Singapore 1.077
Ashburn 814
Fairfield 673
Chandler 589
Dong Ket 514
Hong Kong 480
Hefei 423
Seattle 340
Wilmington 325
Woodbridge 318
Princeton 277
Bologna 267
Houston 253
Jacksonville 246
Dallas 245
Ann Arbor 231
Cambridge 226
Ho Chi Minh City 210
Beijing 205
Dublin 201
Santa Clara 200
Boardman 177
Hanoi 174
Seoul 160
Padova 129
Westminster 127
Bern 121
Nanjing 118
Tokyo 105
Milan 101
Berlin 99
Los Angeles 99
Abidjan 86
Lomé 85
New York 85
Buffalo 74
Sofia 72
Medford 70
Jinan 68
Saint Petersburg 63
Shenyang 61
Changsha 49
Zhengzhou 47
Hebei 46
Mülheim 46
Bengaluru 44
Redondo Beach 43
Tianjin 43
Parma 40
Amman 39
Nanchang 38
Abeokuta 37
San Diego 37
Shanghai 37
Florence 36
Helsinki 34
Buenos Aires 33
Rome 33
Haiphong 32
Bremen 31
Redwood City 31
Brussels 30
Fremont 28
Mahé 27
Hangzhou 26
Jiaxing 25
Dearborn 24
São Paulo 24
Guangzhou 23
Verona 23
Yubileyny 23
Frankfurt am Main 21
Ningbo 21
Vienna 21
Olalla 20
Phoenix 20
Pune 20
Toronto 20
Des Moines 19
London 19
Taizhou 19
Modena 17
Biên Hòa 16
Munich 16
Turin 16
Shenzhen 15
Shijiazhuang 15
Taiyuan 15
Mountain View 14
Redmond 14
Wuhan 14
Bắc Ninh 13
Fuzhou 13
Jakarta 13
Norwalk 13
Tappahannock 13
Warsaw 13
Falkenstein 12
Falls Church 12
Totale 12.837
Salva come PNG Salva come JPEG
Nome #
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens 305
Antiviral activity of brincidofovir on parvovirus B19 250
Restriction Factors expression decreases in HIV-1 patients after cART 232
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 228
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 219
Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy 213
Antiviral effect of cidofovir on parvovirus B19 replication 196
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 195
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 190
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 188
Next Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity 186
The clinical use of parvovirus B19 assays: recent advances 183
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 182
Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one derivatives and study of their antiviral activity against parvovirus B19 181
Advances in the development of antiviral strategies against parvovirus B19 181
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 179
A Parvovirus B19 synthetic genome: sequence features and functional competence 179
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 178
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 175
Characterization of the human DNA gut virome across populations with different subsistence strategies and geographical origin 175
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 174
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 173
A portable Microfluidic Device Based on Chemiluminescence Contact Imaging for detecting Parvovirus B19 in serum samples 171
A proteomic approach to the analysis of B19 capsid proteins 169
Parvovirus B19 Achievements and Challenges 168
A Functional Minigenome of Parvovirus B19 168
A loop mediated isothermal amplification (LAMP) assay to detect viral DNA in clinical specimens: BK polyomavirus and parvovirus B19 166
Parvoviridae 166
Antiviral effect of Hydroxyurea on B19V replication 165
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 163
Recurrent erythema in patients with long-term parvovirus B19 infection 162
Analisi della competenza funzionale di cloni genomici di parvovirus B19 159
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 157
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 157
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 156
Detection of viral DNA by isothermal NASBA amplification and chemiluminescence gene probe hybridization assay in a microfluidic cartridge 155
Mesenchymal stem cells are susceptible but non-permissive to B19V replication 155
Simian parvovirus infection: a potential zoonosis 154
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 154
Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas 153
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 152
A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells 152
On-chip LAMP-BART reaction for viral DNA real-time bioluminescence detection 152
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 150
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 150
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 149
Development of chemiluminescent assays for the quantitative detection and imaging of 5-bromo-2'deoxyuridine-labeled DNA in parvovirus B19-infected cells 143
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012–2024: COVID‐19 Pre‐Pandemic, Pandemic and Post‐Pandemic Trends 141
Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells 141
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 141
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay 141
Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells 141
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 140
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 140
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 140
Analysis at single cell level of parvovirus B19 expression process by chemiluminescent microscope imaging assays 138
How does parvovirus B19 DNA achieve lifelong persistence in human cells? 138
No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions 138
Analysis of the functional competence of genomic clones of Parvovirus B19 137
Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells 137
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 136
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 136
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 136
Parvovirus B19 DNA detection in serum samples employing a microfluidic device based on chemiluminescence contact imaging. 135
A loop-mediated isothermal amplification (LAMP) assay to detect parvovirus B19 DNA in clinical samples 135
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 134
Portable chemiluminescence multiplex biosensor for quantitative detection of three B19 DNA genotypes 134
Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication 133
Parvovirus B19-derived fetal complications following gestational infection. 133
Evidence of human bocavirus viremia in healthy blood donors. 133
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays 132
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 132
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 131
Placental endothelial cells can be productively infected by Parvovirus B19 131
Back from the past: Parvovirus B19 Genotype III DNA in the mummies of the Hermit Poor Clares of Fara in Sabina, Italy 130
Tecniche di amplificazione real-time nella determinazione della carica virale: parvovirus B19 e papillomavirus umani 130
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones 129
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 129
Avermectins Inhibit Replication of Parvovirus B19 by Disrupting the Interaction Between Importin α and Non-Structural Protein 1 128
Preliminary bioinformatic evaluation via Snakemake pipeline applied to 17th-18th century mummified specimens 127
null 127
Implicazioni nella progressione della patologia cervicale 126
Analysis on Parvovirus B19 life cycle at single cell level by chemiluminescent imaging assays 126
Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells 126
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 125
Single-cell chemiluminescence imaging of parvovirus B19 life cycle 123
Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-2 122
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 122
Antiviral effect of Cidofovir on B19V replication 121
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 121
Microfluidic cartridge with integrated array of amorphous silicon photosensors for chemiluminescence detection of viral DNA 120
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 119
Parvovirus B19 in Rheumatic Diseases 118
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 118
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 118
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 117
Cellule progenitrici eritroidi ottenute da sangue periferico come sistema per lo studio della replicazione ed espressione di B19V 117
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 116
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 114
Bone marrow necrosis and fat embolism syndrome in sickle cell disease: Increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. 114
Totale 15.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.447 0 0 0 0 0 107 37 87 175 108 88 845
2021/20222.442 232 124 119 193 205 126 55 169 89 197 492 441
2022/20232.561 282 345 128 316 157 168 77 122 423 50 232 261
2023/20241.222 46 127 75 147 101 252 84 94 56 70 83 87
2024/20253.210 152 490 320 233 420 173 282 100 62 159 190 629
2025/20264.450 755 1.070 901 633 870 221 0 0 0 0 0 0
Totale 20.360